JP2003514601A - 性的反応の画像化 - Google Patents

性的反応の画像化

Info

Publication number
JP2003514601A
JP2003514601A JP2001539269A JP2001539269A JP2003514601A JP 2003514601 A JP2003514601 A JP 2003514601A JP 2001539269 A JP2001539269 A JP 2001539269A JP 2001539269 A JP2001539269 A JP 2001539269A JP 2003514601 A JP2003514601 A JP 2003514601A
Authority
JP
Japan
Prior art keywords
contrast agent
sexual
imaging
subject
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001539269A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003514601A5 (enExample
Inventor
ロバート エム． ウェイスコフ，
スティーブン シー． ナイト，
ウェイン カーター，
Original Assignee
エピックス メディカル， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エピックス メディカル， インコーポレイテッド filed Critical エピックス メディカル， インコーポレイテッド
Publication of JP2003514601A publication Critical patent/JP2003514601A/ja
Publication of JP2003514601A5 publication Critical patent/JP2003514601A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/481—Diagnostic techniques involving the use of contrast agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/507—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for determination of haemodynamic parameters, e.g. perfusion CT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/508—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for non-human patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/06—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48—Diagnostic techniques
    • A61B8/481—Diagnostic techniques involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Optics & Photonics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
JP2001539269A 1999-11-22 2000-11-21 性的反応の画像化 Pending JP2003514601A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16725799P 1999-11-22 1999-11-22
US60/167,257 1999-11-22
PCT/US2000/032112 WO2001037630A2 (en) 1999-11-22 2000-11-21 Imaging sexual response

Publications (2)

Publication Number Publication Date
JP2003514601A true JP2003514601A (ja) 2003-04-22
JP2003514601A5 JP2003514601A5 (enExample) 2008-01-17

Family

ID=22606613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001539269A Pending JP2003514601A (ja) 1999-11-22 2000-11-21 性的反応の画像化

Country Status (5)

Country Link
US (3) US6548044B1 (enExample)
EP (1) EP1237593A1 (enExample)
JP (1) JP2003514601A (enExample)
AU (1) AU1791501A (enExample)
WO (1) WO2001037630A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1791501A (en) * 1999-11-22 2001-06-04 Epix Medical, Inc. Imaging sexual response
US20090112197A1 (en) * 2007-10-30 2009-04-30 Searete Llc Devices configured to facilitate release of nitric oxide
US8221690B2 (en) 2007-10-30 2012-07-17 The Invention Science Fund I, Llc Systems and devices that utilize photolyzable nitric oxide donors
US8642093B2 (en) * 2007-10-30 2014-02-04 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
JP4966051B2 (ja) * 2007-02-27 2012-07-04 株式会社東芝 超音波診断支援システム、超音波診断装置、及び超音波診断支援プログラム
US8349262B2 (en) 2007-10-30 2013-01-08 The Invention Science Fund I, Llc Nitric oxide permeable housings
US8877508B2 (en) 2007-10-30 2014-11-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
US20110182970A1 (en) * 2007-10-30 2011-07-28 Hyde Roderick A Nitric oxide sensors and systems
US10080823B2 (en) * 2007-10-30 2018-09-25 Gearbox Llc Substrates for nitric oxide releasing devices
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055176A1 (en) * 1997-06-05 1998-12-10 Astra Aktiebolag A transurethral device

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
IT1269839B (it) 1994-05-26 1997-04-15 Bracco Spa Coniugati di acidi biliari, loro derivati con complessi metallici e relativi usi
WO1996022526A1 (en) 1995-01-17 1996-07-25 W.L. Gore & Associates, Inc. Acoustical apparatus for testing noise generated by fabrics and method for testing
TW319763B (enExample) 1995-02-01 1997-11-11 Epix Medical Inc
US5707605A (en) 1995-06-02 1998-01-13 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
DE19539409C2 (de) 1995-10-11 1999-02-18 Diagnostikforschung Inst Kontrastmittel für die Nahinfrarot-Diagnostik
US5888476A (en) 1996-11-13 1999-03-30 Mallinckrodt Medical, Inc. Magnetic resonance blood pool agents
DE69819925T2 (de) 1997-10-02 2004-09-02 Epix Medical, Inc., Cambridge Kontrastverstärktes Diagnosebildererzeugungsverfahren zur Überwachung von therapeutischen Eingriffen
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
AU1791501A (en) * 1999-11-22 2001-06-04 Epix Medical, Inc. Imaging sexual response

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055176A1 (en) * 1997-06-05 1998-12-10 Astra Aktiebolag A transurethral device

Also Published As

Publication number Publication date
WO2001037630A2 (en) 2001-05-31
US20030129135A1 (en) 2003-07-10
US20060018834A1 (en) 2006-01-26
US6969507B2 (en) 2005-11-29
AU1791501A (en) 2001-06-04
EP1237593A1 (en) 2002-09-11
US6548044B1 (en) 2003-04-15

Similar Documents

Publication Publication Date Title
Pham et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor
US6567684B1 (en) Imaging system, computer, program product and method for detecting changes in rates of water diffusion in a tissue using magnetic resonance imaging (MRI)
Black et al. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas
Sebag et al. Dynamic gadolinium-enhanced subtraction MR imaging–a simple technique for the early diagnosis of Legg-Calve-Perthes disease: preliminary results
Febo et al. Imaging cocaine-induced changes in the mesocorticolimbic dopaminergic system of conscious rats
Lu et al. Contrast-enhanced magnetic resonance imaging of gastric emptying and motility in rats
Laron et al. D-Trp6-analogue of luteinising hormone releasing hormone in combination with cyproterone acetate to treat precocious puberty
US6548044B1 (en) Imaging sexual response
Gupta et al. Disease-related microstructural differences in the brain in women with provoked vestibulodynia
Huang et al. Intraoperative contrast-enhanced ultrasonography for microcirculatory evaluation in rhesus monkey with spinal cord injury
Mineura et al. Positron emission tomographic evaluation of radiochemotherapeutic effect on regional cerebral hemocirculation and metabolism in patients with gliomas
Reimer et al. Application of a superparamagnetic iron oxide (Resovis®) for MR imaging of human cerebral blood volume
Reichle et al. Renal ultrasonographic and computed tomographic appearance, volume, and function of cats with autosomal dominant polycystic kidney disease
Lüdemann et al. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent
Krause et al. MRI of blood volume and cellular uptake of superparamagnetic iron in an animal model of choroidal melanoma
US20030113267A1 (en) Colon contrast enhanced imaging
US20160136306A1 (en) Systems and methods of detecting interstitial cystitis
Pechman et al. Characterization of bevacizumab dose response relationship in U87 brain tumors using magnetic resonance imaging measures of enhancing tumor volume and relative cerebral blood volume
CA2645422A1 (en) Methods of treating cancer using hypofractionated radiation and texaphyrins
Vonken et al. Repeated quantitative perfusion and contrast permeability measurement in the MRI examination of a CNS tumor
Karacostas et al. Cobalamin deficiency: MRI detection of posterior columns involvement and posttreatment resolution
Karpagam et al. A study to assess the role of date syrup, pineapple juice, and hematinic syrup as magnetic resonance oral contrast agents in improving the image quality of magnetic resonance cholangiopancreatography
Krause et al. MRI of blood volume with superparamagnetic iron in choroidal melanoma treated with thermotherapy
Duncan et al. Measurement of hippocampal T2 in epilepsy
Hashemi et al. Comparison of Gadovist and Magnevist in brain Magnetic resonance imaging of multiple sclerosis patients with an acute attack

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071121

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071121

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20101006

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101012

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110304